By Paul Darrel O. Meneses from FJCPPhA, Philippines - IPSF Public Health Committee - Humanitarian Team Member and Policy Committee Member
We all face changes every day – whether it is a simple change in the weather, our schedule or expected change. With new technical breakthroughs and information growth every day, there are improvements in every area of everyday life. The biotechnology field is one that is facing multiple shifts, with continuing studies, technical advances and scientific results. Assume infants born early in the last couple of centuries have little fighting opportunity. Yet babies of twenty-four weeks or older live in high-tech neonatal intensive care units worldwide because of today's modern skills and developments in technology. In this field, the quality of life of all organizations is taken into consideration in all corporations, research institutes and organizations. As far as human wellbeing is concerned, this requires an awareness of illnesses so that the study and testing can help human beings battle such pandemics. Biotechnology is evidently on the rise due to its growth and researchers along with the general public is expecting it will definitely exceed further than USD 775 billion in valuated outcome over the next four following years to come. Such trend is prompted not just by more than the current events, including the COVID-19 pandemic that is currently happening, but also by expanded financial funding following successful studies of potential drug therapies for a wide range of ailments and chronic diseases. Trends dominate the biotech industry today, each with exciting innovations that will advance the field further.
- "Vaccine Development & Research" - In 2021, several biotechnology and pharmaceutical efforts will be enabled in attempts to tackle the COVID-19 pandemic. Much before the end of this year or early 2021 the pharmaceutical industry mobilized unprecedentedly to create a vaccine for COVID-19. There are a variety of promising candidates, including Oxford's vaccine for adenovirus, new mRNA and genetic and inactivated vaccines for the disease. We should look forward to even more in 2021. The first in the new technological period, the existence of the pandemic led to an all-embracing arms race. The increasing production of innovative vaccine technologies along with the strengthened and joint efforts in creating a better technology is important for drug financing efforts and biotech firms.
- "Monoclonal Antibodies" - In 2021, further progress is expected in the area of biosimilars and monoclonal antibodies. Monoclonal antibodies are synthetic antibodies, which can kindle or complement synthetic antibodies that can activate, repair or supplement the reaction of the immune system. They are particularly useful for the supply of targeted medicines to particular cells against cancer cells. Think of them in the fight on cancer as guided rockets or intelligent bombs. Biosimilar compounds are used to replicate the effects of brand-name medications but at a substantially lower cost. This will reduce the cost of new therapies and improve healthcare.
- "Cell and Gene Therapies" - In 2021, experts are expecting a fast rate as businesses begin to deliver at the late stage after positive results in oncology, regenerative medicine and rare diseases. FDA Commissioner Scott Gottlib expects the regulator to confer 10-20 approvals for cell therapy and genetic engineering every year through to 2025, considering the difficulties related to manufacturing capability and size capacity, as biotechnology continues to explore new ventures. Innovative, focused drugs are one of the most notable developments in pharmaceutical development. Cellular and gene therapy are meant for clinical treatments instead of just a generic transmitted approach. This is a positive scientific direction and the coming of personalized medicine can definitely be seen in 2021.
These mentioned trends are indeed a handful of the anticipation that can be expected from biotechnology in 2021. Several COVID-19 vaccines are being developed however, the guaranteed advantages to human healthcare will be considerably oscillate beyond 2021.
- Carleton, Samantha Costanzo (2020, July 14). "EMERGING BIOTECHNOLOGY TRENDS FOR 2021". Retrieved from https://www.northeastern.edu/graduate/blog/biotechnology-trends/
- Sambit (2020, October 06). "5 Crucial Biotech and Big Pharma Research and Development Trends for 2021". Retrieved from https://rankeronline.com/5-crucial-biotech-and-big-pharma-research-and-development-trends-for-2021/
- Linchpin, Team (2020, October 06). "Trends Shaping The Biotechnology Industry Outlook For 2021". Retrieved from https://linchpinseo.com/trends-biotechnology-industry/